Company Filing History:
Years Active: 2021-2024
Title: Innovations by Pushkar Shrinivas Kulkarni
Introduction
Pushkar Shrinivas Kulkarni is an accomplished inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to subcutaneous medicinal dosage implants. With a total of two patents to his name, Kulkarni's work is paving the way for advancements in medical treatments.
Latest Patents
Kulkarni's latest patents include a method of fabricating an extended release subcutaneous medicinal dosage implant system. This method involves creating an implant from a highly homogeneously mixed composition that includes a medicinal agent combined with release-controlling polymers such as poly (DL-lactide) and polycaprolactone. In one implementation aimed at treating opioid diseases, the formulation consists of naltrexone at 40 weight percent, poly (DL-lactide) in the range of 36 to 46.4 weight percent, and polycaprolactone in the range of 24 to 11.6 weight percent. To enhance the anti-biofouling quality and prevent foreign body interactions, polyethylene glycol is added at a preferred content of 2.0%. The manufacturing process utilizes hot melt extrusion and a mini jet-based implant formation stage, with optimized conditions including a temperature range of 170° C to 180° C, mixing times of 8 to 12 minutes, and injection times of 8 to 12 seconds. The resulting implants are uniquely shaped, free of defects, and bioabsorbable.
Career Highlights
Kulkarni is currently associated with Drug Delivery Company, LLC, where he continues to innovate in the field of drug delivery systems. His work focuses on developing advanced solutions that improve patient outcomes and enhance the efficacy of medicinal treatments.
Collaborations
Some of Kulkarni's notable coworkers include Jeffrey David Benner and Steven M Cohen. Their collaborative efforts contribute to the ongoing advancements in drug delivery technologies.
Conclusion
Pushkar Shrinivas Kulkarni's innovative work in the field of drug delivery systems exemplifies the potential of modern medical technologies. His patents reflect a commitment to improving therapeutic methods and patient care.